TIDMGSK

RNS Number : 8169G

GlaxoSmithKline PLC

28 July 2021

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                     Sir Jonathan Symonds 
====  ========================================  ================================================= 
 b)    Position/status                          Non-Executive Chairman 
====  ========================================  ================================================= 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================= 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================= 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 April 2021 to 30 June 
                                                 2021 
====  ========================================  ================================================= 
 c)    Price(s) and                              Price(s)               Volume(s) 
        volume(s) 
====  ========================================   =====================  ======================= 
   GBP14.05                                                             3,113.879 
   ===================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================== 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ================================================= 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Mr Charles Bancroft 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 April 2021 to 30 June 2021 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $39.35                   1,469.711 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                     Mr Vindi Banga 
====  ========================================  ================================================= 
 b)    Position/status                          Senior Independent Non-Executive Director 
====  ========================================  ================================================= 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================= 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================= 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 April 2021 to 30 June 
                                                 2021 
====  ========================================  ================================================= 
 c)    Price(s) and                              Price(s)               Volume(s) 
        volume(s) 
====  ========================================   =====================  ======================= 
   GBP14.05                                                             645.018 
   ===================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================== 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ================================================= 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Dr Anne Beal 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 April 2021 to 30 June 2021 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $39.35                   122.409 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                     Dr Vivienne Cox 
====  ========================================  ================================================= 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ================================================= 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================= 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================= 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 April 2021 to 30 June 
                                                 2021 
====  ========================================  ================================================= 
 c)    Price(s) and                              Price(s)               Volume(s) 
        volume(s) 
====  ========================================   =====================  ======================= 
   GBP14.05                                                             600.534 
   ===================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================== 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ================================================= 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Ms Lynn Elsenhans 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 April 2021 to 30 June 2021 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $39.35                   283.444 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Dr Laurie Glimcher 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 April 2021 to 30 June 2021 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $39.35                   1,049.794 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Dr Jesse Goodman 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 April 2021 to 30 June 2021 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $39.35                   346.432 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                     Mr Urs Rohner 
====  ========================================  ================================================= 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ================================================= 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================= 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================= 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 April 2021 to 30 June 
                                                 2021 
====  ========================================  ================================================= 
 c)    Price(s) and                              Price(s)               Volume(s) 
        volume(s) 
====  ========================================   =====================  ======================= 
   GBP14.05                                                             572.183 
   ===================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ================================================================  ============================== 
 e)    Date of the transaction                  2021-07-28 
====  ========================================  ================================================= 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQVLFLFDLXBBF

(END) Dow Jones Newswires

July 28, 2021 12:32 ET (16:32 GMT)

Glaxosmithkline (LSE:GSK)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Glaxosmithkline Charts.
Glaxosmithkline (LSE:GSK)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Glaxosmithkline Charts.